Edition:
United Kingdom

Swiss Market Report Headlines

Novartis' breast cancer treatment wins FDA approval

The U.S. Food and Drug Administration (FDA) said on Friday it approved Novartis AG's treatment in combination with hormone therapy fulvestrant for postmenopausal women, as well as men, with a form of advanced breast cancer.

Business Video

Top News